Online Inquiry

Trimetlylamine Oxide (TMAO) Analysis Service

Trimethylamine oxide (Trimetlylamine oxide, TMAO) is a small molecule organic compound. In 2011, Cleveland Laboratory, one of the world's top cardiovascular disease medical centers, reported in Nature that TMAO, a metabolite of intestinal bacteria, is related to heart disease. , bringing the small molecule TMAO into the public view.

Targeted metabolomics can collect metabolome data of biological samples through MRM mode for target metabolites of interest to achieve qualitative analysis of metabolites. Combining the external standard quantitative method allows for the absolute quantification of metabolites in the sample using the standard curve of the standard.

TMAO is a low-molecular-weight amine compound with a relatively high content in aquatic products. It is also a metabolite related to intestinal flora. In the human body, intestinal bacteria can metabolize choline and lecithin to produce trimethylamine (TMA), which is then metabolized into TMAO. Trimethylamine oxide also exists in mammals, plants and fungi. Trimethylamine oxide and its metabolites participate in many important biological functions of the body, such as regulating osmotic pressure, stabilizing proteins, preventing protein denaturation, and participating in cell division. Studies have shown that elevated levels of TMAO are significantly positively correlated with cardiovascular diseases, and are closely related to hypertension, cardiac insufficiency, arteriosclerosis and other diseases. Therefore, trimethylamine oxide has received more and more attention. The study of trimethylamine oxide and related metabolites has important reference value in exploring TMAO metabolism, pathogenesis of related diseases, diagnosis, treatment and prevention methods.

Meat Biomarkers (TMAO)

Our TMAO Analysis Service

With integrated set of separation, characterization, identification and quantification systems featured with excellent robustness & reproducibility, high and ultra-sensitivity, Creative Proteomics provides reliable, rapid and cost-effective TMO targeted metabolomics services.

Creative Proteomics has established a robust, reproducible, and highly sensitive HPLC-MS platform for the simultaneous quantification of TMAO. Our high-throughput TMAO detection and analysis technology is based on LC-MS/MS and allows for the absolute quantitative detection of TMAO and its metabolites, including Trimethylamine N-oxide, Trimethylamine, Choline (Choline), Betaine, Creatinine, and L-carnitine. Complete quantitative analysis of TMAO and related metabolites can provide a reliable basis for the study of the etiology and pathology of related diseases.


Advanced Platform: We utilize AB SCIEX QTRAP 6500+, a high-precision and high-resolution targeted detection mass spectrometer, to achieve precise and accurate targeted identification.

Self-built Database: We have independently built the TMAO metabolite database and provided all standard curves for measured substances.

Strict Quality Control: Our dual quality control system includes Standard QC, Sample QC, and exogenous internal standards to ensure data stability and accuracy.

Accurate Qualitative Results: Each compound has more than two pairs of characteristic ion pairs to ensure qualitative accuracy.

Accurate Quantitative Results: We use MRM mode with a triple quadrupole to accurately detect the relative content of substances.

Wide Linear Range: Our correlation coefficient is greater than 0.99, enabling us to perform quantitative analysis on different types of complex samples.


Gut flora research

Cardiovascular research, renal disease research, etc.

Identification of neurotransmitters in samples such as tissue cells;

Research on the pathogenesis of nervous system diseases;



Data Analysis

Analysis TypeAnalysis Content
Difference AnalysisUnivariate Statistical Analysis T Test
Box Plots
Functional AnalysisHierarchical Cluster Analysis
KEGG Analysis
Advanced Bioinformatics AnalysisRegression Analysis
Trend Cluster Analysis
Machine Learning ROC
Metabolites Quantified in This Service
Trimethylamine (TMA)
Trimethylamine N-oxide (TMAO)

Sample Requirement

Blood (serum, plasma) ≥200 μL

Animal tissue ≥120 mg

Feces ≥200 mg


  1. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk. Journal of the American College of Cardiology. 2020.
  2. Development of a gut microbe–targeted nonlethal therapeutic to inhibit thrombosis potential. Nature Medicine, 2018.
* For Research Use Only. Not for use in diagnostic procedures.
Our customer service representatives are available 24 hours a day, 7 days a week. Inquiry

Online Inquiry

Please submit a detailed description of your project. We will provide you with a customized project plan to meet your research requests. You can also send emails directly to for inquiries.

* Email
* Service & Products of Interest
Services Required and Project Description
* Verification Code
Verification Code
5-20% Discount 5-20% Discount